Genomics & CRISPR Market Likely to Surpass ~USD 134 Billion by 2035

Buy Now

A significant study discovering the market avenues on, “Genomics & CRISPR Market Size, Share & Trends Analysis Report by Technology Type (CRISPR-Cas9, CRISPR-Cas12, CRISPR-Cas13, Y CRISPR-Cas14, Base Editing, Prime Editing, TALENs, ZFNs, Next-Generation Sequencing, Others), Product & Service, Application, Therapeutic Area, Delivery Method, End-User, Mode, Design Type, and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) – Global Industry Data, Trends, and Forecasts, 2025–2035” A holistic view of the market pathways in the genomics & CRISPR market underscores revenue acceleration through three key levers scalable product line extensions, high‑maturity strategic partnerships.

Global Genomics & CRISPR Market Forecast 2035:

According to the report, the global genomics & CRISPR market is projected to expand from USD 27.4 billion in 2025 to ~USD 134 billion by 2035, registering a CAGR of 17.2%, the highest during the forecast period. The global Genomics and CRISPR industry is one of the most disruptive fields in life sciences, combining the high-level sequencing, bioinformatics, and gene-editing technologies in order to make precision medicine, agricultural innovation, and therapeutic development faster. Genomics allows studying of genetic data in large scale to gain insight into the mechanism of diseases, to facilitate personalized medicine, and drug discovery, whereas CRISPR has already transformed genome editing by offering a precise, efficient and cost-effective way of modifying DNA. Collectively, these technologies are disrupting the domains of healthcare, biotechnology, and agriculture, making it easier to create gene therapies, diagnostic devices and genetically modified crops.

The growth of the market is driven by the falling cost of sequencing, fast developments in data analytics as well as increased government and other players investments aimed at enhancing infrastructure of the field of genomic research. Additionally, cross-industry partnerships have made biotechnology companies, academies and pharmaceutical companies innovate and fast-track the clinical translation of CRISPR-based therapeutics. North America has been leading on this development because it has been heavily funded, has good research ecosystems and has good regulatory environments whilst Europe and Asia-Pacific have been growing as key players with growing genomic medicine programs and uptake of technology. On balance, the upcoming merger of genomics and CRISPR technologies is transforming the future of medicine and biotechnology, and it has the potential to change the approaches to the prevention and treatment of diseases as well as to a sustainable innovation of biological practice like never before.

“Key Driver, Restraint, and Growth Opportunity Shaping the Global Genomics & CRISPR Market”

The combination of genomics and CRISPR technologies has revolutionized the drug discovery process by allowing more precise and rapid identification and confirmation of therapeutic targets that result in the expansion of genomics and CRISPR market. Genomic data can enable researchers to comprehend the genetic foundations of diseases, novel biomarkers, and drug responses and CRISPR-based technologies can enable direct functional investigations by editing or silencing particular genes in order to understand their atomic role in pathways of disease. This speeds up preclinical developments, lowers the development expenses, and increases the chances of drugs candidates of the development passing on to clinical trials. CRISPR screening technology and genomics-based data are becoming a valuable asset used by pharmaceutical and biotechnology companies to develop the next generation medications, such as gene and cell-based therapies.

Advanced genomic and gene-editing therapies are very specific in their production, and facilities, personnel, and high-quality standards are required, which makes the mass produced costly and time-intensive. Stability, purity and consistency of biological materials like viral vectors, CRISPR components or engineered cells are technically challenging to maintain. Also, the absence of unified production guidelines and the shortage of quality raw materials also limit scalability. Such aspects raise the cost of production, the duration of development and load-bearing the process of its commercial-scale implementation, limiting the affordability and accessibility of these therapies to more patients.

Genomic and CRISPR research integration with Artificial Intelligence (AI) is an excellent transformative prospect of discoveries and clinical application driven by precision. AI is also able to save time-to-insight and to increase the accuracy of genome editing processes by automating variant detection, target prediction and off-target assessment. The technology accelerates and makes the genetic information practical regarding therapeutic applications by bridging complicated genomic data with effective response-based therapeutic results. Besides, the implementation of cloud-based analytics and predictive modeling can facilitate the scalable applications in the field of clinical diagnostics, drug discovery and personalized medicine. Indicatively, in 2025 Thermo Fisher Scientific has enhanced its Ion Torrent Genexus AI-driven sequencing system, which can real-time variant calling and prediction of CRISPR-targets using adaptive machine learning algorithms.

Regional Analysis of Global Genomics & CRISPR Market

The genomics and CRISPR market in North America is regarded as the most promising in the world with an effective ecosystem of research excellence, funding resources, and commercial innovation. They include the presence of major players in the market, as well as leading academic institutions that lead the research in gene-editing in the region. Strong NIH and government funding schemes such as the Somatic Cell Genome Editing (SCGE) project keep pace with innovation in the development of genome editing technologies and delivery platforms. Moreover, the large number of using precision medicine and the increasing investment of venture capital firms and the positive regulatory and intellectual property environment reinforce the leadership in North America. The growing clinical trial activity, the growing biotech hubs in the U.S. and Canada, and the powerful industry-academia cooperation are yet another reason to consider the region as the home of genomics and CRISPR technology innovation.
The Asia Pacific region will grow the largest in genomics and CRISPR market because of the increasing number of investments in biotechnology, increase in healthcare expenditure, rise in demand on newer therapeutics, increase in incidence of chronic and lifestyle diseases, and the number of clinical research systems in countries such as China, Japan and South Korea. In addition, the presence of positive government programs and collaboration between local biotech companies and foreign drug manufacturers are also leading to the development of the market in the region. An example is On World Health Day, Genome Labs highlighted that genetic testing helps to identify the genetic risks to the fetus early on, before performing interventions to eliminate them and provide healthy pregnancies, and this reinforced the importance of genomics in helping to improve maternal and fetal health in India.

Prominent players operating in the global genomics & CRISPR market are Agilent Technologies, Beam Therapeutics, Caribou Biosciences, Cellecta, CRISPR Therapeutics, Danaher Corporation, Editas Medicine, GenScript Biotech, Horizon Discovery (Revvity), Illumina, Integrated DNA Technologies (IDT), Intellia Therapeutics, Lonza Group, Merck KGaA, New England Biolabs, OriGene Technologies, PerkinElmer, Qiagen, Synthego, Takara Bio, Thermo Fisher Scientific, and Other Key Players.

The global genomics & CRISPR market has been segmented as follows:

Global Genomics & CRISPR Market Analysis, By Technology Type

CRISPR-Cas9
CRISPR-Cas12
CRISPR-Cas13
CRISPR-Cas14
Base Editing
Prime Editing
TALENs (Transcription Activator-Like Effector Nucleases)
ZFNs (Zinc Finger Nucleases)
Next-Generation Sequencing (NGS)
Others

Global Genomics & CRISPR Market Analysis, By Product & Service

Reagents & Consumables
- gRNA
- Cas Enzymes
- Vectors & Plasmids
- Delivery Systems
- Others
Software & Bioinformatics
- Design Tools
- Analysis Software
- Data Management Platforms
- Others
Instruments & Equipment
- Sequencers
- PCR Machines
- Electroporation Systems
- Others
Services
- Cell Line Engineering
- Genotyping Services
- Gene Synthesis
- Library Preparation
- Others

Global Genomics & CRISPR Market Analysis, By Application

Biomedical Research
Drug Discovery & Development
Agricultural Biotechnology
Diagnostic Applications
Therapeutic Applications
Industrial Biotechnology
Others

Global Genomics & CRISPR Market Analysis, By Therapeutic Area

Oncology
Genetic Disorders
Cardiovascular Diseases
Infectious Diseases
Neurological Disorders
Hematological Disorders
Immunological Disorders
Rare Diseases
Others

Global Genomics & CRISPR Market Analysis, By Delivery Method

Viral Delivery
- Adeno-Associated Virus (AAV)
- Lentivirus
- Adenovirus
- Others
Non-Viral Delivery
- Electroporation
- Microinjection
- Lipofection
- Nanoparticles
- Others

Global Genomics & CRISPR Market Analysis, By End-User

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations (CROs)
Hospitals & Diagnostic Centers
Agricultural Companies
Industrial Biotechnology Firms

Global Genomics & CRISPR Market Analysis, By Mode

Ex Vivo
In Vivo
In Vitro

Global Genomics & CRISPR Market Analysis, By Design Type

gRNA Design & Vector Construction
Cell Line Development
Animal Model Engineering
Plant Genome Engineering

Global Genomics & CRISPR Market Analysis, By Region

North America
Europe
Asia Pacific
Middle East
Africa
South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact Us

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

1. Research Methodology and Assumptions
- 1.1. Definitions
- 1.2. Research Design and Approach
- 1.3. Data Collection Methods
- 1.4. Base Estimates and Calculations
- 1.5. Forecasting Models
  - 1.5.1. Key Forecast Factors & Impact Analysis
- 1.6. Secondary Research
  - 1.6.1. Open Sources
  - 1.6.2. Paid Databases
  - 1.6.3. Associations
- 1.7. Primary Research
  - 1.7.1. Primary Sources
  - 1.7.2. Primary Interviews with Stakeholders across Ecosystem
2. Executive Summary
- 2.1. Global Genomics & CRISPR Market Outlook
  - 2.1.1. Genomics & CRISPR Market Size (Value - US$ Bn), and Forecasts, 2021-2035
  - 2.1.2. Compounded Annual Growth Rate Analysis
  - 2.1.3. Growth Opportunity Analysis
  - 2.1.4. Segmental Share Analysis
  - 2.1.5. Geographical Share Analysis
- 2.2. Market Analysis and Facts
- 2.3. Supply-Demand Analysis
- 2.4. Competitive Benchmarking
- 2.5. Go-to- Market Strategy
  - 2.5.1. Customer/ End-use Industry Assessment
  - 2.5.2. Growth Opportunity Data, 2025-2035
    - 2.5.2.1. Regional Data
    - 2.5.2.2. Country Data
    - 2.5.2.3. Segmental Data
  - 2.5.3. Identification of Potential Market Spaces
  - 2.5.4. GAP Analysis
  - 2.5.5. Potential Attractive Price Points
  - 2.5.6. Prevailing Market Risks & Challenges
  - 2.5.7. Preferred Sales & Marketing Strategies
  - 2.5.8. Key Recommendations and Analysis
  - 2.5.9. A Way Forward
3. Industry Data and Premium Insights
- 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
  - 3.1.1. Healthcare & Pharmaceutical Industry Ecosystem Analysis
  - 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
  - 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
- 3.2. Supplier Customer Data
- 3.3. Technology Roadmap and Developments
- 3.4. Trade Analysis
  - 3.4.1. Import & Export Analysis, 2025
  - 3.4.2. Top Importing Countries
  - 3.4.3. Top Exporting Countries
- 3.5. Trump Tariff Impact Analysis
  - 3.5.1. Manufacturer
    - 3.5.1.1. Based on the component & Raw material
  - 3.5.2. Supply Chain
  - 3.5.3. End Consumer
- 3.6. Raw Material Analysis
4. Market Overview
- 4.1. Market Dynamics
  - 4.1.1. Drivers
    - 4.1.1.1. Rising demand for precision and personalized medicine
    - 4.1.1.2. Advancements in next-generation sequencing and CRISPR technologies
    - 4.1.1.3. Increasing investments in genomics-based drug discovery and diagnostics
  - 4.1.2. Restraints
    - 4.1.2.1. Ethical and regulatory concerns surrounding human gene editing
    - 4.1.2.2. High cost of genomic research and CRISPR implementation
- 4.2. Key Trend Analysis
- 4.3. Regulatory Framework
  - 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
  - 4.3.2. Tariffs and Standards
  - 4.3.3. Impact Analysis of Regulations on the Market
- 4.4. Ecosystem Analysis
- 4.5. Porter’s Five Forces Analysis
- 4.6. PESTEL Analysis
- 4.7. Global Genomics & CRISPR Market Demand
  - 4.7.1. Historical Market Size - in Value (US$ Bn), 2020-2024
  - 4.7.2. Current and Future Market Size - in Value (US$ Bn), 2025–2035
    - 4.7.2.1. Y-o-Y Growth Trends
    - 4.7.2.2. Absolute $ Opportunity Assessment
5. Competition Landscape
- 5.1. Competition structure
  - 5.1.1. Fragmented v/s consolidated
- 5.2. Company Share Analysis, 2025
  - 5.2.1. Global Company Market Share
  - 5.2.2. By Region
    - 5.2.2.1. North America
    - 5.2.2.2. Europe
    - 5.2.2.3. Asia Pacific
    - 5.2.2.4. Middle East
    - 5.2.2.5. Africa
    - 5.2.2.6. South America
- 5.3. Product Comparison Matrix
  - 5.3.1. Specifications
  - 5.3.2. Market Positioning
  - 5.3.3. Pricing
6. Global Genomics & CRISPR Market Analysis, By Technology Type
- 6.1. Key Segment Analysis
- 6.2. Genomics & CRISPR Market Size (Value - US$ Bn), Analysis, and Forecasts, By Technology Type, 2021-2035
  - 6.2.1. CRISPR-Cas9
  - 6.2.2. CRISPR-Cas12
  - 6.2.3. CRISPR-Cas13
  - 6.2.4. CRISPR-Cas14
  - 6.2.5. Base Editing
  - 6.2.6. Prime Editing
  - 6.2.7. TALENs (Transcription Activator-Like Effector Nucleases)
  - 6.2.8. ZFNs (Zinc Finger Nucleases)
  - 6.2.9. Next-Generation Sequencing (NGS)
  - 6.2.10. Others
7. Global Genomics & CRISPR Market Analysis, By Product & Service
- 7.1. Key Segment Analysis
- 7.2. Genomics & CRISPR Market Size (Value - US$ Bn), Analysis, and Forecasts, By Product & Service, 2021-2035
  - 7.2.1. Reagents & Consumables
    - 7.2.1.1. gRNA
    - 7.2.1.2. Cas Enzymes
    - 7.2.1.3. Vectors & Plasmids
    - 7.2.1.4. Delivery Systems
    - 7.2.1.5. Others
  - 7.2.2. Software & Bioinformatics
    - 7.2.2.1. Design Tools
    - 7.2.2.2. Analysis Software
    - 7.2.2.3. Data Management Platforms
    - 7.2.2.4. Others
  - 7.2.3. Instruments & Equipment
    - 7.2.3.1. Sequencers
    - 7.2.3.2. PCR Machines
    - 7.2.3.3. Electroporation Systems
    - 7.2.3.4. Others
  - 7.2.4. Services
    - 7.2.4.1. Cell Line Engineering
    - 7.2.4.2. Genotyping Services
    - 7.2.4.3. Gene Synthesis
    - 7.2.4.4. Library Preparation
    - 7.2.4.5. Others
8. Global Genomics & CRISPR Market Analysis and Forecasts,By Application
- 8.1. Key Findings
- 8.2. Genomics & CRISPR Market Size (Value - US$ Mn), Analysis, and Forecasts, By Application, 2021-2035
  - 8.2.1. Biomedical Research
  - 8.2.2. Drug Discovery & Development
  - 8.2.3. Agricultural Biotechnology
  - 8.2.4. Diagnostic Applications
  - 8.2.5. Therapeutic Applications
  - 8.2.6. Industrial Biotechnology
  - 8.2.7. Others
9. Global Genomics & CRISPR Market Analysis and Forecasts, By Therapeutic Area
- 9.1. Key Findings
- 9.2. Genomics & CRISPR Market Size (Vo Value - US$ Mn), Analysis, and Forecasts, Therapeutic Area, 2021-2035
  - 9.2.1. Oncology
  - 9.2.2. Genetic Disorders
  - 9.2.3. Cardiovascular Diseases
  - 9.2.4. Infectious Diseases
  - 9.2.5. Neurological Disorders
  - 9.2.6. Hematological Disorders
  - 9.2.7. Immunological Disorders
  - 9.2.8. Rare Diseases
  - 9.2.9. Others
10. Global Genomics & CRISPR Market Analysis and Forecasts, By Delivery Method
- 10.1. Key Findings
- 10.2. Genomics & CRISPR Market Size (Value - US$ Mn), Analysis, and Forecasts, By Delivery Method, 2021-2035
  - 10.2.1. Viral Delivery
    - 10.2.1.1. Adeno-Associated Virus (AAV)
    - 10.2.1.2. Lentivirus
    - 10.2.1.3. Adenovirus
    - 10.2.1.4. Others
  - 10.2.2. Non-Viral Delivery
    - 10.2.2.1. Electroporation
    - 10.2.2.2. Microinjection
    - 10.2.2.3. Lipofection
    - 10.2.2.4. Nanoparticles
    - 10.2.2.5. Others
11. Global Genomics & CRISPR Market Analysis and Forecasts, By End-User
- 11.1. Key Findings
- 11.2. Genomics & CRISPR Market Size (Value - US$ Mn), Analysis, and Forecasts, By End-User, 2021-2035
  - 11.2.1. Pharmaceutical & Biotechnology Companies
  - 11.2.2. Academic & Research Institutes
  - 11.2.3. Contract Research Organizations (CROs)
  - 11.2.4. Hospitals & Diagnostic Centers
  - 11.2.5. Agricultural Companies
  - 11.2.6. Industrial Biotechnology Firms
12. Global Genomics & CRISPR Market Analysis and Forecasts, By Mode
- 12.1. Key Findings
- 12.2. Genomics & CRISPR Market Size (Value - US$ Mn), Analysis, and Forecasts, By Mode, 2021-2035
  - 12.2.1. Ex Vivo
  - 12.2.2. In Vivo
  - 12.2.3. In Vitro
13. Global Genomics & CRISPR Market Analysis and Forecasts, By Design Type
- 13.1. Key Findings
- 13.2. Genomics & CRISPR Market Size (Value - US$ Mn), Analysis, and Forecasts, By Design Type, 2021-2035
  - 13.2.1. gRNA Design & Vector Construction
  - 13.2.2. Cell Line Development
  - 13.2.3. Animal Model Engineering
  - 13.2.4. Plant Genome Engineering
14. Global Genomics & CRISPR Market Analysis and Forecasts, by Region
- 14.1. Key Findings
- 14.2. Genomics & CRISPR Market Size (Value - US$ Mn), Analysis, and Forecasts, by Region, 2021-2035
  - 14.2.1. North America
  - 14.2.2. Europe
  - 14.2.3. Asia Pacific
  - 14.2.4. Middle East
  - 14.2.5. Africa
  - 14.2.6. South America
15. North America Genomics & CRISPR Market Analysis
- 15.1. Key Segment Analysis
- 15.2. Regional Snapshot
- 15.3. North America Genomics & CRISPR Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 15.3.1. Technology Type
  - 15.3.2. Product & Service
  - 15.3.3. Application
  - 15.3.4. Therapeutic Area
  - 15.3.5. Delivery Method
  - 15.3.6. End-User
  - 15.3.7. Mode
  - 15.3.8. Design Type
  - 15.3.9. Country
    - 15.3.9.1. USA
    - 15.3.9.2. Canada
    - 15.3.9.3. Mexico
- 15.4. USA Genomics & CRISPR Market
  - 15.4.1. Country Segmental Analysis
  - 15.4.2. Technology Type
  - 15.4.3. Product & Service
  - 15.4.4. Application
  - 15.4.5. Therapeutic Area
  - 15.4.6. Delivery Method
  - 15.4.7. End-User
  - 15.4.8. Mode
  - 15.4.9. Design Type
- 15.5. Canada Genomics & CRISPR Market
  - 15.5.1. Country Segmental Analysis
  - 15.5.2. Technology Type
  - 15.5.3. Product & Service
  - 15.5.4. Application
  - 15.5.5. Therapeutic Area
  - 15.5.6. Delivery Method
  - 15.5.7. End-User
  - 15.5.8. Mode
  - 15.5.9. Design Type
- 15.6. Mexico Genomics & CRISPR Market
  - 15.6.1. Country Segmental Analysis
  - 15.6.2. Technology Type
  - 15.6.3. Product & Service
  - 15.6.4. Application
  - 15.6.5. Therapeutic Area
  - 15.6.6. Delivery Method
  - 15.6.7. End-User
  - 15.6.8. Mode
  - 15.6.9. Design Type
16. Europe Genomics & CRISPR Market Analysis
- 16.1. Key Segment Analysis
- 16.2. Regional Snapshot
- 16.3. Europe Genomics & CRISPR Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 16.3.1. Therapeutic Application
  - 16.3.2. Technology Type
  - 16.3.3. Product & Service
  - 16.3.4. Application
  - 16.3.5. Therapeutic Area
  - 16.3.6. Delivery Method
  - 16.3.7. End-User
  - 16.3.8. Mode
  - 16.3.9. Design Type
  - 16.3.10. Country
    - 16.3.10.1. Germany
    - 16.3.10.2. United Kingdom
    - 16.3.10.3. France
    - 16.3.10.4. Italy
    - 16.3.10.5. Spain
    - 16.3.10.6. Netherlands
    - 16.3.10.7. Nordic Countries
    - 16.3.10.8. Poland
    - 16.3.10.9. Russia & CIS
    - 16.3.10.10. Rest of Europe
- 16.4. Germany Genomics & CRISPR Market
  - 16.4.1. Country Segmental Analysis
  - 16.4.2. Technology Type
  - 16.4.3. Product & Service
  - 16.4.4. Application
  - 16.4.5. Therapeutic Area
  - 16.4.6. Delivery Method
  - 16.4.7. End-User
  - 16.4.8. Mode
  - 16.4.9. Design Type
- 16.5. United Kingdom Genomics & CRISPR Market
  - 16.5.1. Country Segmental Analysis
  - 16.5.2. Technology Type
  - 16.5.3. Product & Service
  - 16.5.4. Application
  - 16.5.5. Therapeutic Area
  - 16.5.6. Delivery Method
  - 16.5.7. End-User
  - 16.5.8. Mode
  - 16.5.9. Design Type
- 16.6. France Genomics & CRISPR Market
  - 16.6.1. Country Segmental Analysis
  - 16.6.2. Technology Type
  - 16.6.3. Product & Service
  - 16.6.4. Application
  - 16.6.5. Therapeutic Area
  - 16.6.6. Delivery Method
  - 16.6.7. End-User
  - 16.6.8. Mode
  - 16.6.9. Design Type
- 16.7. Italy Genomics & CRISPR Market
  - 16.7.1. Country Segmental Analysis
  - 16.7.2. Technology Type
  - 16.7.3. Product & Service
  - 16.7.4. Application
  - 16.7.5. Therapeutic Area
  - 16.7.6. Delivery Method
  - 16.7.7. End-User
  - 16.7.8. Mode
  - 16.7.9. Design Type
- 16.8. Spain Genomics & CRISPR Market
  - 16.8.1. Technology Type
  - 16.8.2. Product & Service
  - 16.8.3. Application
  - 16.8.4. Therapeutic Area
  - 16.8.5. Delivery Method
  - 16.8.6. End-User
  - 16.8.7. Mode
  - 16.8.8. Design Type
- 16.9. Netherlands Genomics & CRISPR Market
  - 16.9.1. Country Segmental Analysis
  - 16.9.2. Technology Type
  - 16.9.3. Product & Service
  - 16.9.4. Application
  - 16.9.5. Therapeutic Area
  - 16.9.6. Delivery Method
  - 16.9.7. End-User
  - 16.9.8. Mode
  - 16.9.9. Design Type
- 16.10. Nordic Countries Genomics & CRISPR Market
  - 16.10.1. Country Segmental Analysis
  - 16.10.2. Technology Type
  - 16.10.3. Product & Service
  - 16.10.4. Application
  - 16.10.5. Therapeutic Area
  - 16.10.6. Delivery Method
  - 16.10.7. End-User
  - 16.10.8. Mode
  - 16.10.9. Design Type
- 16.11. Poland Genomics & CRISPR Market
  - 16.11.1. Country Segmental Analysis
  - 16.11.2. Technology Type
  - 16.11.3. Product & Service
  - 16.11.4. Application
  - 16.11.5. Therapeutic Area
  - 16.11.6. Delivery Method
  - 16.11.7. End-User
  - 16.11.8. Mode
  - 16.11.9. Design Type
- 16.12. Russia & CIS Genomics & CRISPR Market
  - 16.12.1. Country Segmental Analysis
  - 16.12.2. Technology Type
  - 16.12.3. Product & Service
  - 16.12.4. Application
  - 16.12.5. Therapeutic Area
  - 16.12.6. Delivery Method
  - 16.12.7. End-User
  - 16.12.8. Mode
  - 16.12.9. Design Type
- 16.13. Rest of Europe Genomics & CRISPR Market
  - 16.13.1. Country Segmental Analysis
  - 16.13.2. Technology Type
  - 16.13.3. Product & Service
  - 16.13.4. Application
  - 16.13.5. Therapeutic Area
  - 16.13.6. Delivery Method
  - 16.13.7. End-User
  - 16.13.8. Mode
  - 16.13.9. Design Type
17. Asia Pacific Genomics & CRISPR Market Analysis
- 17.1. Key Segment Analysis
- 17.2. Regional Snapshot
- 17.3. East Asia Genomics & CRISPR Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 17.3.1. Therapeutic Application
  - 17.3.2. Technology Type
  - 17.3.3. Product & Service
  - 17.3.4. Application
  - 17.3.5. Therapeutic Area
  - 17.3.6. Delivery Method
  - 17.3.7. End-User
  - 17.3.8. Mode
  - 17.3.9. Design Type
  - 17.3.10. Country
    - 17.3.10.1. China
    - 17.3.10.2. India
    - 17.3.10.3. Japan
    - 17.3.10.4. South Korea
    - 17.3.10.5. Australia and New Zealand
    - 17.3.10.6. Indonesia
    - 17.3.10.7. Malaysia
    - 17.3.10.8. Thailand
    - 17.3.10.9. Vietnam
    - 17.3.10.10. Rest of Asia Pacific
- 17.4. China Genomics & CRISPR Market
  - 17.4.1. Country Segmental Analysis
  - 17.4.2. Technology Type
  - 17.4.3. Product & Service
  - 17.4.4. Application
  - 17.4.5. Therapeutic Area
  - 17.4.6. Delivery Method
  - 17.4.7. End-User
  - 17.4.8. Mode
  - 17.4.9. Design Type
- 17.5. India Genomics & CRISPR Market
  - 17.5.1. Country Segmental Analysis
  - 17.5.2. Technology Type
  - 17.5.3. Product & Service
  - 17.5.4. Application
  - 17.5.5. Therapeutic Area
  - 17.5.6. Delivery Method
  - 17.5.7. End-User
  - 17.5.8. Mode
  - 17.5.9. Design Type
- 17.6. Japan Genomics & CRISPR Market
  - 17.6.1. Country Segmental Analysis
  - 17.6.2. Technology Type
  - 17.6.3. Product & Service
  - 17.6.4. Application
  - 17.6.5. Therapeutic Area
  - 17.6.6. Delivery Method
  - 17.6.7. End-User
  - 17.6.8. Mode
  - 17.6.9. Design Type
- 17.7. South Korea Genomics & CRISPR Market
  - 17.7.1. Country Segmental Analysis
  - 17.7.2. Technology Type
  - 17.7.3. Product & Service
  - 17.7.4. Application
  - 17.7.5. Therapeutic Area
  - 17.7.6. Delivery Method
  - 17.7.7. End-User
  - 17.7.8. Mode
  - 17.7.9. Design Type
- 17.8. Australia and New Zealand Genomics & CRISPR Market
  - 17.8.1. Country Segmental Analysis
  - 17.8.2. Technology Type
  - 17.8.3. Product & Service
  - 17.8.4. Application
  - 17.8.5. Therapeutic Area
  - 17.8.6. Delivery Method
  - 17.8.7. End-User
  - 17.8.8. Mode
  - 17.8.9. Design Type
- 17.9. Indonesia Genomics & CRISPR Market
  - 17.9.1. Country Segmental Analysis
  - 17.9.2. Technology Type
  - 17.9.3. Product & Service
  - 17.9.4. Application
  - 17.9.5. Therapeutic Area
  - 17.9.6. Delivery Method
  - 17.9.7. End-User
  - 17.9.8. Mode
  - 17.9.9. Design Type
- 17.10. Malaysia Genomics & CRISPR Market
  - 17.10.1. Country Segmental Analysis
  - 17.10.2. Technology Type
  - 17.10.3. Product & Service
  - 17.10.4. Application
  - 17.10.5. Therapeutic Area
  - 17.10.6. Delivery Method
  - 17.10.7. End-User
  - 17.10.8. Mode
  - 17.10.9. Design Type
- 17.11. Thailand Genomics & CRISPR Market
  - 17.11.1. Country Segmental Analysis
  - 17.11.2. Technology Type
  - 17.11.3. Product & Service
  - 17.11.4. Application
  - 17.11.5. Therapeutic Area
  - 17.11.6. Delivery Method
  - 17.11.7. End-User
  - 17.11.8. Mode
  - 17.11.9. Design Type
- 17.12. Vietnam Genomics & CRISPR Market
  - 17.12.1. Country Segmental Analysis
  - 17.12.2. Source/Origin
  - 17.12.3. Technology Type
  - 17.12.4. Product & Service
  - 17.12.5. Application
  - 17.12.6. Therapeutic Area
  - 17.12.7. Delivery Method
  - 17.12.8. End-User
  - 17.12.9. Mode
  - 17.12.10. Design Type
- 17.13. Rest of Asia Pacific Genomics & CRISPR Market
  - 17.13.1. Country Segmental Analysis
  - 17.13.2. Technology Type
  - 17.13.3. Product & Service
  - 17.13.4. Application
  - 17.13.5. Therapeutic Area
  - 17.13.6. Delivery Method
  - 17.13.7. End-User
  - 17.13.8. Mode
  - 17.13.9. Design Type
18. Middle East Genomics & CRISPR Market Analysis
- 18.1. Key Segment Analysis
- 18.2. Regional Snapshot
- 18.3. Middle East Genomics & CRISPR Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 18.3.1. Therapeutic Application
  - 18.3.2. Technology Type
  - 18.3.3. Product & Service
  - 18.3.4. Application
  - 18.3.5. Therapeutic Area
  - 18.3.6. Delivery Method
  - 18.3.7. End-User
  - 18.3.8. Mode
  - 18.3.9. Design Type
  - 18.3.10. Country
    - 18.3.10.1. Turkey
    - 18.3.10.2. UAE
    - 18.3.10.3. Saudi Arabia
    - 18.3.10.4. Israel
    - 18.3.10.5. Rest of Middle East
- 18.4. Turkey Genomics & CRISPR Market
  - 18.4.1. Country Segmental Analysis
  - 18.4.2. Technology Type
  - 18.4.3. Product & Service
  - 18.4.4. Application
  - 18.4.5. Therapeutic Area
  - 18.4.6. Delivery Method
  - 18.4.7. End-User
  - 18.4.8. Mode
  - 18.4.9. Design Type
- 18.5. UAE Genomics & CRISPR Market
  - 18.5.1. Country Segmental Analysis
  - 18.5.2. Technology Type
  - 18.5.3. Product & Service
  - 18.5.4. Application
  - 18.5.5. Therapeutic Area
  - 18.5.6. Delivery Method
  - 18.5.7. End-User
  - 18.5.8. Mode
  - 18.5.9. Design Type
- 18.6. Saudi Arabia Genomics & CRISPR Market
  - 18.6.1. Country Segmental Analysis
  - 18.6.2. Technology Type
  - 18.6.3. Product & Service
  - 18.6.4. Application
  - 18.6.5. Therapeutic Area
  - 18.6.6. Delivery Method
  - 18.6.7. End-User
  - 18.6.8. Mode
  - 18.6.9. Design Type
- 18.7. Israel Genomics & CRISPR Market
  - 18.7.1. Country Segmental Analysis
  - 18.7.2. Technology Type
  - 18.7.3. Product & Service
  - 18.7.4. Application
  - 18.7.5. Therapeutic Area
  - 18.7.6. Delivery Method
  - 18.7.7. End-User
  - 18.7.8. Mode
  - 18.7.9. Design Type
- 18.8. Rest of Middle East Genomics & CRISPR Market
  - 18.8.1. Country Segmental Analysis
  - 18.8.2. Technology Type
  - 18.8.3. Product & Service
  - 18.8.4. Application
  - 18.8.5. Therapeutic Area
  - 18.8.6. Delivery Method
  - 18.8.7. End-User
  - 18.8.8. Mode
  - 18.8.9. Design Type
19. Africa Genomics & CRISPR Market Analysis
- 19.1. Key Segment Analysis
- 19.2. Regional Snapshot
- 19.3. Africa Genomics & CRISPR Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 19.3.1. Technology Type
  - 19.3.2. Product & Service
  - 19.3.3. Application
  - 19.3.4. Therapeutic Area
  - 19.3.5. Delivery Method
  - 19.3.6. End-User
  - 19.3.7. Mode
  - 19.3.8. Design Type
  - 19.3.9. Country
    - 19.3.9.1. South Africa
    - 19.3.9.2. Egypt
    - 19.3.9.3. Nigeria
    - 19.3.9.4. Algeria
    - 19.3.9.5. Rest of Africa
- 19.4. South Africa Genomics & CRISPR Market
  - 19.4.1. Country Segmental Analysis
  - 19.4.2. Technology Type
  - 19.4.3. Product & Service
  - 19.4.4. Application
  - 19.4.5. Therapeutic Area
  - 19.4.6. Delivery Method
  - 19.4.7. End-User
  - 19.4.8. Mode
  - 19.4.9. Design Type
- 19.5. Egypt Genomics & CRISPR Market
  - 19.5.1. Country Segmental Analysis
  - 19.5.2. Technology Type
  - 19.5.3. Product & Service
  - 19.5.4. Application
  - 19.5.5. Therapeutic Area
  - 19.5.6. Delivery Method
  - 19.5.7. End-User
  - 19.5.8. Mode
  - 19.5.9. Design Type
- 19.6. Nigeria Genomics & CRISPR Market
  - 19.6.1. Country Segmental Analysis
  - 19.6.2. Technology Type
  - 19.6.3. Product & Service
  - 19.6.4. Application
  - 19.6.5. Therapeutic Area
  - 19.6.6. Delivery Method
  - 19.6.7. End-User
  - 19.6.8. Mode
  - 19.6.9. Design Type
- 19.7. Algeria Genomics & CRISPR Market
  - 19.7.1. Country Segmental Analysis
  - 19.7.2. Technology Type
  - 19.7.3. Product & Service
  - 19.7.4. Application
  - 19.7.5. Therapeutic Area
  - 19.7.6. Delivery Method
  - 19.7.7. End-User
  - 19.7.8. Mode
  - 19.7.9. Design Type
- 19.8. Rest of Africa Genomics & CRISPR Market
  - 19.8.1. Country Segmental Analysis
  - 19.8.2. Technology Type
  - 19.8.3. Product & Service
  - 19.8.4. Application
  - 19.8.5. Therapeutic Area
  - 19.8.6. Delivery Method
  - 19.8.7. End-User
  - 19.8.8. Mode
  - 19.8.9. Design Type
20. South America Genomics & CRISPR Market Analysis
- 20.1. Key Segment Analysis
- 20.2. Regional Snapshot
- 20.3. Central and South Africa Genomics & CRISPR Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 20.3.1. Technology Type
  - 20.3.2. Product & Service
  - 20.3.3. Application
  - 20.3.4. Therapeutic Area
  - 20.3.5. Delivery Method
  - 20.3.6. End-User
  - 20.3.7. Mode
  - 20.3.8. Design Type
  - 20.3.9. Country
    - 20.3.9.1. Brazil
    - 20.3.9.2. Argentina
    - 20.3.9.3. Rest of South America
- 20.4. Brazil Genomics & CRISPR Market
  - 20.4.1. Country Segmental Analysis
  - 20.4.2. Technology Type
  - 20.4.3. Product & Service
  - 20.4.4. Application
  - 20.4.5. Therapeutic Area
  - 20.4.6. Delivery Method
  - 20.4.7. End-User
  - 20.4.8. Mode
  - 20.4.9. Design Type
- 20.5. Argentina Genomics & CRISPR Market
  - 20.5.1. Country Segmental Analysis
  - 20.5.2. Technology Type
  - 20.5.3. Product & Service
  - 20.5.4. Application
  - 20.5.5. Therapeutic Area
  - 20.5.6. Delivery Method
  - 20.5.7. End-User
  - 20.5.8. Mode
  - 20.5.9. Design Type
- 20.6. Rest of South America Genomics & CRISPR Market
  - 20.6.1. Country Segmental Analysis
  - 20.6.2. Technology Type
  - 20.6.3. Product & Service
  - 20.6.4. Application
  - 20.6.5. Therapeutic Area
  - 20.6.6. Delivery Method
  - 20.6.7. End-User
  - 20.6.8. Mode
  - 20.6.9. Design Type
21. Key Players/ Company Profile
- 21.1. Agilent Technologies
  - 21.1.1. Company Details/ Overview
  - 21.1.2. Company Financials
  - 21.1.3. Key Customers and Competitors
  - 21.1.4. Business/ Industry Portfolio
  - 21.1.5. Product Portfolio/ Specification Details
  - 21.1.6. Pricing Data
  - 21.1.7. Strategic Overview
  - 21.1.8. Recent Developments
- 21.2. Beam Therapeutics
- 21.3. Caribou Biosciences
- 21.4. Cellecta
- 21.5. CRISPR Therapeutics
- 21.6. Danaher Corporation
- 21.7. Editas Medicine
- 21.8. GenScript Biotech
- 21.9. Horizon Discovery (Revvity)
- 21.10. Illumina
- 21.11. Integrated DNA Technologies (IDT)
- 21.12. Intellia Therapeutics
- 21.13. Lonza Group
- 21.14. Merck KGaA
- 21.15. New England Biolabs
- 21.16. OriGene Technologies
- 21.17. PerkinElmer
- 21.18. Qiagen
- 21.19. Synthego
- 21.20. Takara Bio
- 21.21. Thermo Fisher Scientific
- 21.22. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF

PRICING DETAILS

Single-User Upto 2 Users - [PDF + Excel Only]

USD 4150

Multi-User Upto 10 Users - [PDF + Excel + PPT]

USD 5950

Enterprise-User Company-wide - [Report Pack + Benchmark + 6M Update]

USD 7750

Related Report

Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation